Decoy Therapeutics shareholders approve warrant issuance and authorized share reduction

Decoy Therapeutics Inc.

Special meeting held 9/14/2026; quorum 46.03% of 590,185 shares outstanding.
Proposal 1 passed: 81,646 for, 2,906 against, 196 abstain approving Milestone Warrant share issuance.
Proposal 2 passed: 234,494 for, 6,303 against, 181 abstain to cut authorized shares by 10M to 90M.
Adjournment proposal moot since both proposals approved by majority of votes cast.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.